000 01417 a2200409 4500
005 20250513200305.0
264 0 _c20000204
008 200002s 0 0 eng d
022 _a0946-1965
040 _aNLM
_beng
_cNLM
100 1 _aKanerva, H
245 0 0 _aPharmacokinetics and safety of deramciclane during multiple oral dosing.
_h[electronic resource]
260 _bInternational journal of clinical pharmacology and therapeutics
_cDec 1999
300 _a589-97 p.
_bdigital
500 _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial
650 0 4 _aAdministration, Oral
650 0 4 _aAdult
650 0 4 _aAnti-Anxiety Agents
_xadministration & dosage
650 0 4 _aBiological Availability
650 0 4 _aBlood Pressure
_xdrug effects
650 0 4 _aCamphanes
_xadministration & dosage
650 0 4 _aDouble-Blind Method
650 0 4 _aElectrocardiography
_xdrug effects
650 0 4 _aHeart Rate
_xdrug effects
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aSerotonin Antagonists
_xadministration & dosage
700 1 _aKilkku, O
700 1 _aHelminen, A
700 1 _aRouru, J
700 1 _aScheinin, M
700 1 _aHuupponen, R
700 1 _aKlebovich, I
700 1 _aDrabant, S
700 1 _aUrtti, A
773 0 _tInternational journal of clinical pharmacology and therapeutics
_gvol. 37
_gno. 12
_gp. 589-97
999 _c10556025
_d10556025